Topical imiquimod as neoadjuvant therapy before Mohs micrographic surgery for basal cell carcinoma in the head and neck region: findings from a large retrospective study
- PMID: 33997952
- DOI: 10.1111/bjd.20487
Topical imiquimod as neoadjuvant therapy before Mohs micrographic surgery for basal cell carcinoma in the head and neck region: findings from a large retrospective study
References
-
- Ferlay J, Ervik M, Lam F. World Health Organization International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today. 2018. Available at: https://gco.iarc.fr/today (last accessed 9 June 2021).
-
- Huber A, Huber JD, Skinner RB Jr et al. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series. Dermatol Surg 2004; 30:429-30.
-
- Butler DF, Parekh PK, Lenis A. Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study. Dermatol Surg 2009; 35:24-9.
-
- Torres A, Niemeyer A, Berkes B et al. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma. Dermatol Surg 2004; 30:1462-9.
-
- Ezughah FI, Affleck AG, Evans A et al. Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs’ micrographic surgery following treatment with imiquimod 5% cream. J Dermatolog Treat 2008; 19:156-8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
